RANCHO CORDOVA, Calif., Jan. 02, 2018 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (“Cesca”) (NASDAQ:KOOL) a market leader in automated cell processing and point-of-care, autologous cell-based therapies, today announced that Chris Xu, Ph.D., chief executive officer, will be presenting at Biotech Showcase on Tuesday, January 9, 2018 at 4:00pm PST. The conference is being held January 8-10, 2018 at the Hilton San Francisco Union Square.
A live webcast of the presentation will be available at:
https://event.webcasts.com/starthere.jsp?ei=1176627&tp_key=d941414f85. The webcast will be archived for 90 days.
About Cesca Therapeutics Inc.
Cesca is a leading regenerative medicine company that develops, commercializes and markets a range of automated technologies for cell-based therapeutics. Its device division, ThermoGenesis, provides a full suite of solutions for automated clinical biobanking, point-of-care applications, and automation for immuno-oncology. Cesca is also leveraging its proprietary AutoXpress® technology platform to develop an automated, functionally-closed CAR-TXpress platform that addresses cellular manufacturing needs in the immuno-oncology field.
Cesca Therapeutics Inc.